Iridex Corp (IRIX) 9.95 $IRIX
Iridex Shares Up 19.1% Since SmarTrend's Buy Recommendation (IRIX)
Comtex SmarTrend(R) - Tue Feb 10, 9:32AM CST
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on November 7th, 2014 at $7.98. In approximately 3 months, Iridex has returned 19.12% as of today's recent price of $9.50.
IRIX: 9.95 (unch)
Iridex Up 18.2% Since SmarTrend Uptrend Call (IRIX)
Comtex SmarTrend(R) - Tue Feb 03, 9:09AM CST
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on November 7th, 2014 at $7.98. In approximately 3 months, Iridex has returned 18.24% as of today's recent price of $9.43.
IRIX: 9.95 (unch)
5 Small-Cap Health Care Stocks You Never Heard of But Should Consider for 2015
at The Street - Mon Feb 02, 7:39AM CST
The health care equipment and supplies may not seem like the sexiest of places to invest, but the sector has a positive outlook, according to TheStreet Ratings.
PMD: 15.26 (-0.14), IRIX: 9.95 (unch), FONR: 12.19 (+0.05), DRAD: 4.50 (+0.08), SPAN: 18.30 (-0.15), KEQU: 17.50 (-0.12)
IRIDEX Receives FDA Clearance for Cyclo G6(TM) Laser System for the Treatment of Multiple Stages of Glaucoma
PR Newswire - Mon Feb 02, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its first laser system designed solely for use in treating glaucoma and its symptoms. Specifically, the Company was granted 510(k) clearance for the IRIDEX Cyclo G6 Laser System (with delivery devices). The Cyclo G6 laser system is dedicated specifically to treat patients diagnosed with a range of glaucoma disease states and features the Company's proprietary MicroPulse tissue-sparing technology and a family of single use probes that connect to an intuitive, user-friendly laser console.
IRIX: 9.95 (unch)
Emerging Diagnostic Imaging Market 2014-2020: Nuclear Imaging Systems, 3D imaging, Tactile imaging, Tomography, Emerging Diagnostic Biomarkers, Wearable diagnostic devices
M2 - Tue Jan 20, 4:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/q69qj6/emerging) has announced the addition of the "Emerging Diagnostic Imaging Market - Devices, Global Industry Analysis, Growth, Trends, Forecast, Growth, Strategies and Opportunities - 2014-2020" report to their offering. Diagnostic Imaging Technologies provide imagery feedback on a patient's physical condition, which is then used to diagnose, monitor or treat medical conditions, thus playing an important role in improving public health of all age groups. X-ray based examinations are crucial in all medical settings and are utilised at every level. While practicing preventive as well as curative medicine, effective medical decisions require precise diagnostics, which technological advancements have significantly enhanced. These technological advancements initially started out with simple X-rays but have now revolutionized medical care in terms of diagnostics. Radiography, MRIs, CT scans, ultrasound, etc. have created a strong market in this field proving to be valuable and necessary investments are pouring in. Newer technologies have made diagnosis less invasive and more accurate, for example elastography tests the elasticity of organs, tactile sensing technology helps in minimum invasive surgery etc. This market is one of the few markets that have seen strong growth in both developed, and developing countries with significant investments specifically from hospitals, all over the globe. Medical Imaging and Technology Alliance (MITA), a branch of National Electrical Manufacturing Association (NEMA) is a collective representation of this market's R&D developers, manufacturers and innovators. Key Topics Covered: 1. Executive Summary 2. Emerging Diagnostic Imaging Technologies: Introduction 3. Market Overview 4. Drivers of Diagnostic Imaging Technologies 5. Restraints of Diagnostic Imaging Technologies 6. Opportunities of Diagnostic Imaging Technologies 7. Challenges of Diagnostic Imaging Technologies 8. Segmentation 9. Competitive Landscape 10. Geography Analysis 11. Company Profiling - Lumenis Ltd. - Biolase - Photomedex - IRIDEX corporation - Spectranetics Corporation For more information visit http://www.researchandmarkets.com/research/q69qj6/emerging
SPNC: 33.69 (-0.06), IRIX: 9.95 (unch), LMNS: 10.80 (+0.57)
Iridex reports preliminary results and provides outlook for 2015
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 7:35AM CST
IRIX: 9.95 (unch)
Shares of IRIX Up 16.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 13, 10:33AM CST
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on November 7th, 2014 at $7.98. In approximately 2 months, Iridex has returned 15.99% as of today's recent price of $9.25.
IRIX: 9.95 (unch)
IRIDEX Announces Preliminary Unaudited Revenues for 2014 Fourth Quarter and Full Year; 2015 Revenue Outlook
PR Newswire - Mon Jan 12, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) today reported preliminary revenues of approximately $11.5 to $11.7 million and $42.5 to $42.7 million for the fourth quarter and full year 2014, respectively. Preliminary revenues in the fourth quarter exceeded the high end of the Company's guidance and were driven by a continued strong uptick in sales of MicroPulse(TM) laser systems both in the U.S. and internationally. Management had projected revenues to be between $10.9 million and $11.2 million in the fourth quarter of 2014.
IRIX: 9.95 (unch)
Medical Laser Veteran George R. Marcellino, Ph.D. Appointed to IRIDEX Board of Directors
PR Newswire - Wed Dec 31, 3:05PM CST
IRIDEX Corporation (NASDAQ:IRIX) announced today that it has appointed ophthalmology and medical laser executive George R. Marcellino, Ph.D., to its Board of Directors, effective immediately. Dr. Marcellino is a co-founder of Sunnyvale, CA-based OptiMedica Corporation, and he fills the seat vacated by James B. Hawkins, who is rotating off the Board after 7 years of service to the IRIDEX shareholders.
IRIX: 9.95 (unch)
IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions
PR Newswire - Tue Dec 02, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) announced today that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced ophthalmology solutions to patients across vast areas of China's rural regions.
IRIX: 9.95 (unch)
IRIDEX Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment
PR Newswire - Wed Nov 19, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) announced today that it has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.
IRIX: 9.95 (unch)
Iridex (IRIX) Upgraded From Hold to Buy
at The Street - Wed Nov 05, 8:11AM CST
Iridex (IRIX) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
IRIX: 9.95 (unch)
IRIDEX's (IRIX) CEO Will Moore on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:17PM CDT
IRIX: 9.95 (unch)
IRIDEX beats by $0.03
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:24PM CDT
IRIX: 9.95 (unch)
IRIDEX Reports 2014 Third Quarter, Nine-Month Results
PR Newswire - Thu Oct 30, 3:05PM CDT
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 27, 2014.
IRIX: 9.95 (unch)
Downtrend Call Working As Iridex Stock Falls 16.2% (IRIX)
Comtex SmarTrend(R) - Thu Oct 30, 9:59AM CDT
SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on July 8th, 2014 at $7.92. In approximately 4 months, Iridex has returned 16.23% as of today's recent price of $6.63.
IRIX: 9.95 (unch)
IRIDEX Announces Third Quarter 2014 Conference Call and Release Date
PR Newswire - Thu Oct 23, 3:05PM CDT
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its third quarter 2014 financial results after the market closes on Thursday, October 30, 2014. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, October 30, 2014 to discuss the results of the quarter and other business developments.
IRIX: 9.95 (unch)
Iridex Down 14.1% Since SmarTrend Downtrend Call (IRIX)
Comtex SmarTrend(R) - Thu Oct 23, 9:30AM CDT
SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on July 8th, 2014 at $7.92. In approximately 4 months, Iridex has returned 14.09% as of today's recent price of $6.80.
IRIX: 9.95 (unch)
IRIDEX to Host MicroPulse® Worldwide 3-Day Forum at the American Academy of Ophthalmology
PR Newswire - Fri Oct 17, 5:30AM CDT
IRIDEX Corporation (Nasdaq:IRIX) announced today its Speakers' Forum program at the annual meeting of the American Academy of Ophthalmology to be held on October 18 - 21 at McCormick Place in Chicago. The Forum consists of a comprehensive 3-day schedule of activities at the IRIDEX booth featuring 13 MicroPulse presentations by 14 leading physicians, 8 of which are new to the IRIDEX podium.
IRIX: 9.95 (unch)
IRIDEX Expands Retinal Portfolio
PR Newswire - Tue Oct 14, 5:30AM CDT
IRIDEX Corporation (Nasdaq:IRIX) announced today that it will introduce its new family of patented Adjustable & Intuitive Extended Reach (A&I XR) laser probes at the annual meeting of the American Academy of Ophthalmology to be held October 18 - 21 at McCormick Place in Chicago. The A&I XR laser probes are used for laser photocoagulation during vitreoretinal procedures. These new devices offer unprecedented uniformity and consistency of treatment using both straight and angled configurations that allow the surgeon to comfortably reach all parts of the anatomy.
IRIX: 9.95 (unch)
Iridex Shares Up 19.1% Since SmarTrend's Buy Recommendation (IRIX)
Comtex SmarTrend(R) - Tue Feb 10, 9:32AM CST
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on November 7th, 2014 at $7.98. In approximately 3 months, Iridex has returned 19.12% as of today's recent price of $9.50.
IRIX: 9.95 (unch)
Iridex Up 18.2% Since SmarTrend Uptrend Call (IRIX)
Comtex SmarTrend(R) - Tue Feb 03, 9:09AM CST
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on November 7th, 2014 at $7.98. In approximately 3 months, Iridex has returned 18.24% as of today's recent price of $9.43.
IRIX: 9.95 (unch)
5 Small-Cap Health Care Stocks You Never Heard of But Should Consider for 2015
at The Street - Mon Feb 02, 7:39AM CST
The health care equipment and supplies may not seem like the sexiest of places to invest, but the sector has a positive outlook, according to TheStreet Ratings.
PMD: 15.26 (-0.14), IRIX: 9.95 (unch), FONR: 12.19 (+0.05), DRAD: 4.50 (+0.08), SPAN: 18.30 (-0.15), KEQU: 17.50 (-0.12)
IRIDEX Receives FDA Clearance for Cyclo G6(TM) Laser System for the Treatment of Multiple Stages of Glaucoma
PR Newswire - Mon Feb 02, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its first laser system designed solely for use in treating glaucoma and its symptoms. Specifically, the Company was granted 510(k) clearance for the IRIDEX Cyclo G6 Laser System (with delivery devices). The Cyclo G6 laser system is dedicated specifically to treat patients diagnosed with a range of glaucoma disease states and features the Company's proprietary MicroPulse tissue-sparing technology and a family of single use probes that connect to an intuitive, user-friendly laser console.
IRIX: 9.95 (unch)
Emerging Diagnostic Imaging Market 2014-2020: Nuclear Imaging Systems, 3D imaging, Tactile imaging, Tomography, Emerging Diagnostic Biomarkers, Wearable diagnostic devices
M2 - Tue Jan 20, 4:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/q69qj6/emerging) has announced the addition of the "Emerging Diagnostic Imaging Market - Devices, Global Industry Analysis, Growth, Trends, Forecast, Growth, Strategies and Opportunities - 2014-2020" report to their offering. Diagnostic Imaging Technologies provide imagery feedback on a patient's physical condition, which is then used to diagnose, monitor or treat medical conditions, thus playing an important role in improving public health of all age groups. X-ray based examinations are crucial in all medical settings and are utilised at every level. While practicing preventive as well as curative medicine, effective medical decisions require precise diagnostics, which technological advancements have significantly enhanced. These technological advancements initially started out with simple X-rays but have now revolutionized medical care in terms of diagnostics. Radiography, MRIs, CT scans, ultrasound, etc. have created a strong market in this field proving to be valuable and necessary investments are pouring in. Newer technologies have made diagnosis less invasive and more accurate, for example elastography tests the elasticity of organs, tactile sensing technology helps in minimum invasive surgery etc. This market is one of the few markets that have seen strong growth in both developed, and developing countries with significant investments specifically from hospitals, all over the globe. Medical Imaging and Technology Alliance (MITA), a branch of National Electrical Manufacturing Association (NEMA) is a collective representation of this market's R&D developers, manufacturers and innovators. Key Topics Covered: 1. Executive Summary 2. Emerging Diagnostic Imaging Technologies: Introduction 3. Market Overview 4. Drivers of Diagnostic Imaging Technologies 5. Restraints of Diagnostic Imaging Technologies 6. Opportunities of Diagnostic Imaging Technologies 7. Challenges of Diagnostic Imaging Technologies 8. Segmentation 9. Competitive Landscape 10. Geography Analysis 11. Company Profiling - Lumenis Ltd. - Biolase - Photomedex - IRIDEX corporation - Spectranetics Corporation For more information visit http://www.researchandmarkets.com/research/q69qj6/emerging
SPNC: 33.69 (-0.06), IRIX: 9.95 (unch), LMNS: 10.80 (+0.57)
Iridex reports preliminary results and provides outlook for 2015
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 7:35AM CST
IRIX: 9.95 (unch)
Shares of IRIX Up 16.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 13, 10:33AM CST
SmarTrend identified an Uptrend for Iridex (NASDAQ:IRIX) on November 7th, 2014 at $7.98. In approximately 2 months, Iridex has returned 15.99% as of today's recent price of $9.25.
IRIX: 9.95 (unch)
IRIDEX Announces Preliminary Unaudited Revenues for 2014 Fourth Quarter and Full Year; 2015 Revenue Outlook
PR Newswire - Mon Jan 12, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) today reported preliminary revenues of approximately $11.5 to $11.7 million and $42.5 to $42.7 million for the fourth quarter and full year 2014, respectively. Preliminary revenues in the fourth quarter exceeded the high end of the Company's guidance and were driven by a continued strong uptick in sales of MicroPulse(TM) laser systems both in the U.S. and internationally. Management had projected revenues to be between $10.9 million and $11.2 million in the fourth quarter of 2014.
IRIX: 9.95 (unch)
Medical Laser Veteran George R. Marcellino, Ph.D. Appointed to IRIDEX Board of Directors
PR Newswire - Wed Dec 31, 3:05PM CST
IRIDEX Corporation (NASDAQ:IRIX) announced today that it has appointed ophthalmology and medical laser executive George R. Marcellino, Ph.D., to its Board of Directors, effective immediately. Dr. Marcellino is a co-founder of Sunnyvale, CA-based OptiMedica Corporation, and he fills the seat vacated by James B. Hawkins, who is rotating off the Board after 7 years of service to the IRIDEX shareholders.
IRIX: 9.95 (unch)
IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions
PR Newswire - Tue Dec 02, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) announced today that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced ophthalmology solutions to patients across vast areas of China's rural regions.
IRIX: 9.95 (unch)
IRIDEX Secures Large Tender from Government of Zambia for Ophthalmology Laser Equipment
PR Newswire - Wed Nov 19, 5:30AM CST
IRIDEX Corporation (Nasdaq:IRIX) announced today that it has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.
IRIX: 9.95 (unch)
Iridex (IRIX) Upgraded From Hold to Buy
at The Street - Wed Nov 05, 8:11AM CST
Iridex (IRIX) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
IRIX: 9.95 (unch)
IRIDEX's (IRIX) CEO Will Moore on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:17PM CDT
IRIX: 9.95 (unch)
IRIDEX beats by $0.03
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:24PM CDT
IRIX: 9.95 (unch)
IRIDEX Reports 2014 Third Quarter, Nine-Month Results
PR Newswire - Thu Oct 30, 3:05PM CDT
IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 27, 2014.
IRIX: 9.95 (unch)
Downtrend Call Working As Iridex Stock Falls 16.2% (IRIX)
Comtex SmarTrend(R) - Thu Oct 30, 9:59AM CDT
SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on July 8th, 2014 at $7.92. In approximately 4 months, Iridex has returned 16.23% as of today's recent price of $6.63.
IRIX: 9.95 (unch)
IRIDEX Announces Third Quarter 2014 Conference Call and Release Date
PR Newswire - Thu Oct 23, 3:05PM CDT
IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its third quarter 2014 financial results after the market closes on Thursday, October 30, 2014. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, October 30, 2014 to discuss the results of the quarter and other business developments.
IRIX: 9.95 (unch)
Iridex Down 14.1% Since SmarTrend Downtrend Call (IRIX)
Comtex SmarTrend(R) - Thu Oct 23, 9:30AM CDT
SmarTrend identified a Downtrend for Iridex (NASDAQ:IRIX) on July 8th, 2014 at $7.92. In approximately 4 months, Iridex has returned 14.09% as of today's recent price of $6.80.
IRIX: 9.95 (unch)
IRIDEX to Host MicroPulse® Worldwide 3-Day Forum at the American Academy of Ophthalmology
PR Newswire - Fri Oct 17, 5:30AM CDT
IRIDEX Corporation (Nasdaq:IRIX) announced today its Speakers' Forum program at the annual meeting of the American Academy of Ophthalmology to be held on October 18 - 21 at McCormick Place in Chicago. The Forum consists of a comprehensive 3-day schedule of activities at the IRIDEX booth featuring 13 MicroPulse presentations by 14 leading physicians, 8 of which are new to the IRIDEX podium.
IRIX: 9.95 (unch)
IRIDEX Expands Retinal Portfolio
PR Newswire - Tue Oct 14, 5:30AM CDT
IRIDEX Corporation (Nasdaq:IRIX) announced today that it will introduce its new family of patented Adjustable & Intuitive Extended Reach (A&I XR) laser probes at the annual meeting of the American Academy of Ophthalmology to be held October 18 - 21 at McCormick Place in Chicago. The A&I XR laser probes are used for laser photocoagulation during vitreoretinal procedures. These new devices offer unprecedented uniformity and consistency of treatment using both straight and angled configurations that allow the surgeon to comfortably reach all parts of the anatomy.
IRIX: 9.95 (unch)
